Sanjivani Paranteral Limited (BOM:531569)
176.75
+0.40 (0.23%)
At close: Nov 6, 2026
Sanjivani Paranteral Revenue
Sanjivani Paranteral had revenue of 254.26M INR in the quarter ending September 30, 2026, with 64.07% growth. This brings the company's total for the last twelve months to 844.92M, up 22.59% year-over-year. In the fiscal year ending March 31, 2026, Sanjivani Paranteral had annual revenue of 686.66M, down -2.04%. That makes Sanjivani Paranteral the 37,850th largest company in the world by revenue and 3,378th in India.
Revenue (ttm)
844.92M
Revenue Growth
+22.59%
P/S Ratio
2.57
Revenue / Employee
19.65M
Employees
43
Market Cap
2.17B
Revenue by Geography
- Middle East & Africa 286.20M 41.7%
- Latin America 224.67M 32.7%
- India & Sub-Continent 157.86M 23.0%
- CIS Countries 17.92M 2.6%
Fiscal year ended Mar 31, 2026 See the full Sanjivani Paranteral breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 686.66M | -14.33M | -2.04% |
| Mar 31, 2025 | 700.99M | 156.88M | 28.83% |
| Mar 31, 2024 | 544.11M | 189.19M | 53.31% |
| Mar 31, 2023 | 354.92M | 48.79M | 15.94% |
| Mar 31, 2022 | 306.13M | 55.13M | 21.96% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 8.38B |
| Sat Kartar Life | 2.24B |
| Ambalal Sarabhai Enterprises | 2.13B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| Accretion Pharmaceuticals | 1.01B |